Multicellular life processes such as proliferation and differentiation depend on cell 4 surface signaling receptors that bind ligands generally referred to as growth factors. 5
to the PNR within five minutes. The novel, cell spanning, fast acting network that we 23 reveal integrates a cascade of events dedicated to the cohort movement of activated 24 EGFR receptors. Our findings support the intriguing proposal that certain endosomal 25 pathways have shed some of the stochastic strategies of traditional trafficking, and 26 have evolved behaviors whose predictability is better suited to signaling [10, 11] . 27
Work presented here demonstrates that our whole cell imaging approach can be a 28 powerful tool in revealing critical transient interactions in key cellular processes such 29 as receptor trafficking. 30 INTRODUCTION 32 33
The endocytic system is critical to a cell's ability to faithfully transduce signals and to 34 process their extracellular environment. At the plasma membrane, EGF stimulation 35 results in multiple parallel processes -transient increases in Ca 2+ [12, 13] , rapid 36 reorganization of actin filaments [14] and formation of new clathrin-coated pits (CCPs) 37
[15]. EGFR has been compared to transferrin in many studies as an example of a 38 3 of 26 ligand-induced, rather than a constitutive receptor, system [16, 17] . Stimulated EGFRs 1 initiate new CCPs that are distinct from transferrin receptor containing CCPs [15, 18, 2 19 ]. Post internalization, the intracellular itineraries of the two receptors are distinct 3 with stimulated EGFR localizing to late endosomes and transferrin receptors recycled 4 back through the early endosomes marked by Rab5[16] . 5 6 Rab5 effectors such as EEA1 and APPL1 and 2 have been shown to be involved in the 7 pre-early endosomal steps of endosomal maturation [20] . APPL1 can bind directly to 8
Rab5 [21] as well as to a lipid bilayer via a PH BAR domain [22] . APPL1 has been also 9
shown to bind the cytosolic tail of various receptors, including the adiponectin 10 receptor [23] , the nerve growth factor receptor [24] and EGFR [20, 25] via its PTB 11 domain. Following endocytosis, EGFR has been shown to enter a population of 12 endosomes marked by APPL1 [10, 20, 26] . It has also been demonstrated that 13 endosomes bearing a subset of clathrin dependent cargoes, including EGFR, are 14 more mobile and mature faster post internalization [27] , compared to those that carry 15 transferrin. To better understand the apparent central role of APPL1 in regulating 16 EGFR, its relation to the observed rapid dynamics of EGF bearing endosomes, and 17 more generally, the molecular events and processes that lead to intracellular 18 divergence of EGFR and transferrin receptors, we measure the dynamics of the newly 19 formed EGF bearing endosomes as well as APPL1 within the first ten minutes of 20 stimulation by EGF. Capitalizing on the rapid volumetric imaging capabilities of 21
Lattice Light-Sheet Microscopy (LLSM), we visualized the first events of internalization 22 of EGF stimulated receptors and discovered that 1. APPL1 relocates from pre-existing 23 endosomes onto EGFR puncta and 2. APPL1 binding to EGFR results in a cohort, 24 dynein mediated movement of EGFR towards the peri-nuclear region of the cell 25 where the endosomal maturation and signal quenching of EGFRs occur. The 26 presented novel behavior of EGF bearing endosomes is a significant detail in 27 understanding signal processing by live cells that has not been described elsewhere 28 to our knowledge. 29 30 RESULTS 
31
APPL1 responds to EGF stimulation by binding immediately to EGFR bearing 32 endosomes and display enhanced retrograde motility. 33
To investigate the whole cell distribution of APPL1 on receptor bearing endosomes 34 following internalization of fluorescently labeled EGF or transferrin in living HeLa cells 35 transfected with APPL1-eGFP, we took advantage of the more rapid volumetric 36 imaging and decreased photo-bleaching offered by a lattice light-sheet microscope 37
[9] (LLSM). Fast multi-color, whole-cell imaging revealed the temporal dynamics of all 38 fluorescently labeled endosomal populations. To capture the first cargo bearing 39 4 of 26 endosomes post-internalization with a time resolution of 4 s for an entire volume of a 1 cell, we devised a setup that allowed us to inject EGF or transferrin as a temporal 2 pulse during image acquisition ( Supplementary Fig. 1 and Supplementary Movie 1). 3 50 µL of 100 nM fluorescently labeled ligand was injected near the imaging region, 4 followed by about 200-300 µL of imaging medium. Thus, in single acquisition 5 sequences of up to 15 min, we could follow the initial binding of ligands to the 6 receptors at the plasma membrane, the appearance of early endosomes formed 7 directly by endocytosis of the ligands, and any of their further movements within the 8 cell; additionally, APPL1 was tracked using APPL1-GFP. We confirmed that the EGF-9 bearing endosomes are not macropinosomes and are likely derived from clathrin 10 mediated endocytosis ( Supplementary Fig. 2 ).
To independently track the 11 coordinates of endosomes labeled with APPL1-eGFP, EGF or transferrin ligands, we 12 performed 2-color (APPL1-GFP and Alexa 647 labeled transferrin or EGF) imaging of 13 whole cells at 4 s per volume (Supplementary Movies 1,2). From the independently 14 tracked coordinates of APPL1-GFP as compared to those of the two other ligands, 15
we quantified the number of spatio-temporally correlated tracks (Methods, 16 Supplementary Fig. 3 ). Both transferrin and EGF appeared as diffuse background 17 fluorescence immediately following injection, and subsequently appeared as 18 punctate structures on the plasma membrane ( Fig. 1a,b ). In the case of transferrin, 19 the punctate structures slowly acquired low levels of APPL1, with an average delay of 20 100 s ( Fig. 1b ,g) (Supplementary Movie 2). In contrast, EGF immediately colocalized 21 with APPL1 at the cell-periphery ( Fig. 1a,d) ), as indicated by the fraction of EGF tracks 22 positive for APPL1 ( Fig. 1d ) and track towards the peri-nuclear region (Supplementary 23 Movie 1). 24
25
To further analyze how APPL1 binding affects EGF bearing endosomes, we 26 developed an analysis workflow that selected the APPL1 tracks that co-tracked with 27 EGF (Fig. 1c ). The overall motility characteristics of these tracks were then determined 28 using mean square mean square displacement analysis [14] . In general, upon addition 29 of EGF, the fraction of APPL1-EGF tracks exhibiting directed motion increased slightly 30 while those with constrained motion decreased ( Fig. 1e,f ). However, by 5 min, of all 31 APPL1 vesicles that showed directed motion, over 80% were also found to be positive 32 for EGF (compare pink/blue curves, Fig. 1e , and columns, Fig. 1f ), indicating that 33 APPL1-EGF-bearing endosomes display a strong tendency towards being more 34 mobile ( Fig. 1 e,f) . In contrast, by 5 min after the addition of transferrin, the APPL1-35 bearing endosomes most likely to show directed movements were those that lacked 36 transferrin ( Fig. 1h ,i). EGF stimulation also resulted in APPL1-bearing endosomes 37 5 of 26 exhibiting longer tracks, and higher maximum velocities, compared to unstimulated 1 cells ( Fig. 2a ). 2 3 EGF bearing APPL1 positive endosomes utilize dynein to move 4
To allow tracking at higher resolution we combined LLSM with micropatterning. On 5 micropatterned coverslips with 5 µm lines, cells acquired an elongated shape 6 (Methods and Supplementary Fig. 4 ). We predicted that the elongated shape of the 7 cells would accentuate the directionality of endosomal movements, which, in the case 8 of EGF-bearing APPL1 endosomes, are expected to occur in a PNR-directed, 9
retrograde manner ( Fig. 2b) . We positioned the lattice light sheet such that an oblique 10 cross-section illuminated the nucleus and adjacent PNR of each cell and acquired 11 images with 200 ms of exposure per frame ( Supplementary Movies 3, 4 ). The number 12 of retrograde movements of APPL1 endosomes in wild-type cells treated with EGF 13 was significantly higher than in unstimulated cells (Fig. 2c, e and Supplementary 14 Movies 3, 4) indicating that EGF stimulation can cause a switch in APPL1 dynamics. 15
While APPL1 is associated with endosomes that exist prior to EGF-stimulation, once 16 it becomes attached to endosomes newly formed by the internalization of EGF, those 17 endosomes are much more likely to move in a retrograde manner. These observations 18 led us to ask three questions: What motors are engaged to enable retrograde 19 movement? What causes APPL1 to switch from pre-existing endosomes to newly 20 generated EGF-bearing endosomes? How does APPL1 localize to EGF bearing 21 endosomes? 22
23
Given the observed retrograde motility of EGF-APPL1-bearing endosomes, we 24 suspected that the main minus-end directed motor, dynein, might be involved. 25
Dynein has also been implicated in the translocation of EGF to the juxta-nuclear 26 region in earlier studies [28] . We expressed a fluorescently labeled version of p150 27 217 -548 tagged with dsRed, which sequesters dynein, thus inhibiting dynein-28 dynactin-based motility [29] . This allowed us to select dsRed-labeled cells, and then 29 assay the motility of their EGF and/or APPL1-bearing endosomes during the first 10 30 min post EGF addition (Supplementary Movie 5). Interestingly, while the total set of 31 APPL1-bearing endosomes did not show a significant change in motility, in the subset 32 that co-tracked with an EGF signal, motility was inhibited ( Fig. 2f) , with a majority of 33 the tracks showing constrained motion (>60%) and only about 15 % showing directed 34 motion ( Fig. 2f ). We also quantified the extent of accumulation of endosomes at the 35 PNR by measuring the distance from the centroid, for all endosomal populations 36 (Methods and Fig. 2g ). In contrast to controls, no accumulation of EGF vesicles in the 37 PNR was observed when cells expressed p150 217 -548 or were treated with another 38 6 of 26 dynein inhibitor, ciliobrevin ( Fig. 2h ). These results indicate that dynein is the major 1 motor protein involved in the translocation of these endosomes. In agreement with 2 this, the EGF-bearing endosomes exhibited a significantly increased fraction of 3 constrained movements under dynein inhibition, in contrast to the large fraction of 4 directed movements seen in untreated cells ( Fig. 2i ). Therefore, independent 5 experiments, that perturb dynein in distinct ways, both suggest that the accumulation 6 of EGF-APPL1-bearing endosomes in the PNR, via minus-end directed translocation, 7 requires the recruitment of dynein. 8 9 APPL1 mediated translocation to the perinuclear region is necessary for efficient 10 maturation of EGF bearing endosomes. 11
Maturation of APPL1 positive endosomes have been shown to occur through a 12 process of conversion, where one protein is shed off the surface of the endosome, 13 and a new endosomal marker is acquired. APPL1 endosomes convert into EEA1 14 positive endosomes. This has also been demonstrated for EGFR containing 15 endosomes. We first recapitulated the maturation of EGF bearing endosomes ( Fig.  16 3a-d). With time, the number of EGF tracks that acquired EEA1 increased with time. 17
Within 5 minutes, a steady fraction of EGF-EEA1 double positive endosome is 18 achieved (Fig. 3d ). As previously described, conversion processes where APPL1 is 19
shed off and EEA1 is acquired were also observed ( Fig. 3c ). Inhibiting retrograde 20 motility by treatment of cells with Ciliobrevin slowed down APPL1 to EEA1 maturation 21 of EGF bearing endosomes (Fig. 3d ). The localization of EGF-APPL1 double positive 22 endosomes therefore, is necessary to maintain the flux of EGF bearing endosomes 23 into EGF-EEA1 double positive endosomes through conversion. 24 25 APPL1 desorption is dependent on calcium wave evoked by EGF stimulation 26
To investigate the observed recruitment of APPL1, from pre-existing to newly formed 27 EGF-bearing endosomes, we analyzed the whole-cell dynamics of APPL1. Upon 28 stimulation with 100 nM EGF, the APPL1 signal was lost from the endosomes of the 29 PNR ( Fig. 4a,b and Supplementary Movie 6, 7) suggesting global redistribution of 30 APPL1. We used Imaris to segment out the PNR to quantify the loss of APPL1 signal 31 from the endosomes. We chose the endosomes at the PNR for this measurement as 32 they are relatively immobile within the time frame of APPL1 desorption, as compared 33 to the peripheral endosomes (Supplementary Movie 8). We found that PNR 34 endosomes lose their APPL1 signal completely or partially when stimulated, 35 respectively, with 100 nM EGF or 20 nM EGF (Fig. 4c ). In contrast, upon transferrin 36 stimulation, we did not observe any APPL1 redistribution. EGF stimulation has been 37 shown to elicit Ca 2+ signals through phospholipase cγ (PLCγ) and phospholipase A2 38 7 of 26 (PLA2) [12, 13] . We speculated that the transient increase in cytosolic Ca 2+ evoked by 1 EGF binding could cause the loss of APPL1 from the endosomes. Previous studies of 2 other proteins that, like APPL1, contain a pleckstrin homology (PH) domain, have 3
shown that elevated intracellular Ca 2+ prevented membrane binding of such proteins 4 through the formation of Ca-phosphoinositide complexes [30] . To determine if 5 elevated Ca 2+ is responsible for the unbinding of APPL1, we imaged the dynamic 6 distribution of APPL1 GFP and the Ca 2+ indicator R-GECO, after using 100 nM 7 ionomycin to induce a Ca 2+ influx ( Fig. 4d and Supplementary Movie 9) [31] . Upon 8 ionomycin addition, APPL1 dissociated from endosomes within 40 s of the R-GECO 9 signal peak ( Fig. 4d ). In all cases of ionomycin-mediated desorption, we observed 10 that the endosomes became transiently immobile, after which APPL1 desorbed from 11 them before subsequently rebinding to endosomes. We attribute the freezing of 12 motile endosomes upon an increase in cytosolic Ca 2+ to 'Calcium-mediated Actin 13
Reset' (CaAR), which results in a dense meshwork of actin [32] . We also measured the 14 time of R-GECO peaks with respect to EGF binding, and APPL1 desorption with 15 respect to EGF binding ( Fig. 4e and Supplementary Movie 10). We found the R-16
GECO signal peaked about 30 s post EGF stimulation, and APPL1 desorption 17 occurred in the next 30 s (Fig. 4e) . 18 19 APPL1 binds to EGFR through its PTB domain 20
It has been previously reported that APPL1 can bind directly to phosphorylated EGFR 21 through its PTB domain. To test whether this interaction plays a role in early stage 22 trafficking of EGFR, cells expressing WT-APPL1 were treated with 10 µM erlotinib for 23 1 h, to inhibit EGFR cross-phosphorylation [33], and imaged following EGF 24 stimulation ( Fig. 5a ). APPL1 localization in these cells was extremely rare and 25 transient. To investigate whether the PTB domain of APPL1 is specifically involved in 26 the binding to EGFR, as suggested elsewhere [25], we expressed a mutant of APPL1 27 with the PTB domain deleted (APPL1-ΔPTB) [34] . We found that APPL1-ΔPTB did not 28 localize to EGF-bearing endosomes and the signals were cytoplasmic. Furthermore, 29
in both experiments, in cells either expressing APPL1-ΔPTB or treated with erlotinib, 30 the peri-nuclear localization and directed motion of EGF-bearing endosomes were 31 strikingly impaired, as demonstrated by the abrogation of the decrease in mean 32 centroid to endosomal distances ( Fig. 5 b,c) . Some mobile endosomes were 33 observed, possibly attributable to kinesins involved in EGFR trafficking [35] . In the 34 case of cells expressing APPL1-ΔPTB, the impaired localization of EGF endosomes in 35 the PNR strongly suggests that this deletion mutant functions as a dominant negative. 36
The experiments together suggest that APPL1 is an intermediary between 37 phosphorylated EGFRs and dynein and is essential for perinuclear accumulation. A mechanism for cohort transport of signaling EGFRs 4
Based on the aforementioned experiments that provide evidence of endosomal 5 dynamics and protein redistributions, in Fig. 6 we present a model of the proposed 6 events involving EGF, EGFR, Ca 2+ , APPL1, and dynein from before, and up to 5 min 7 after, EGF stimulation. Before exposure to EGF, EGFR exists in its monomeric state 8
[36], APPL1 is bound to pre-existing endosomes, and Ca 2+ levels are low. Within 30 9 s of EGF-EGFR binding, EGFR dimerizes and is phosphorylated, endocytosis 10 generates the first EGF-bearing vesicles, and Ca 2+ levels begin to rise. Rising Ca 2+ 11 levels result in the desorption of APPL1 from pre-existing endosomes presumably by 12 Previously, EGFR phosphorylation dynamics, measured using a ratio-metric sensor 21 based on EGFR -ECFP and PTB-YFP, revealed that phosphorylation occurred in less 22 than a minute after EGF addition [37] . This is consistent with the dynamics of APPL1 23 localization to EGFR bearing endosomes, through the PTB domain, observed in our 24 experiments. 25 26 APPL1 as a multifunctional endosomal signaling adaptor protein 27
The multiple interaction sites provided by APPL1's BAR, PH and PTB domains are 28 central to the model. The PTB domain of APPL1 is at the C-terminus and is structurally 29 similar to the PTB domain of Shc [22] , which also binds EGFR [38] . The PTB domain 30 of Shc recognizes NPX(phosphor)Y and has been found to bind tighter to 31 phosphorylated peptides than to phosphatidylinositol [39] and may explain the 32 preference of APPL1 binding to phosphorylated EGFR than the membranes though 33 phosphoinositides. Our experiments with APPL1-ΔPTB, where APPL1 binding to EGF 34 bearing endosomes was impaired, support the fact that the PTB domain of APPL1 35 binds directly to phosphorylated EGFR. Once APPL1 has bound to EGFR, a form of 36 yet unknown interaction appears to engage dynein, and EGF-bearing endosomes are 37 rapidly shunted to the PNR. Our results suggest that dynein acts downstream to 38 9 of 26 APPL1, in that its activity occurs after APPL1 recruitment, and when APPL1 was 1 blocked from binding to EGFR (by erlotinib or APPL1-ΔPTB), no retrograde motility 2 was seen. Dynein has previously been reported to be required for the translocation 3 of EGF towards the nucleus [28] . While direct interactions between dynein and APPL1 4 have not been reported, thirteen key phosphorylation sites have been identified on 5 APPL1, and their functions are yet to be fully elucidated [40] . How APPL1 coupled to 6 EGFR promotes dynein engagement is unknown, however it is possible that APPL1 7 phosphorylation sites are involved. APPL1 phosphorylation has previously been 8 implicated in regulating the recycling of activated GPCRs [41] . Collectively these 9 studies highlight the importance of APPL1 phosphorylation and the need for further 10 investigation of the multiple roles of APPL1 in regulating endosomes. results also agree with the distinct rapid motility previously reported for EGF in 23 contrast to transferrin [27] , and reveal the APPL1 mediated engagement of dynein as 24 a mechanism for these movements. This study reveals that APPL1 is central to this 25 dynein dependent rapid transport, as well as to the peri-nuclear accumulation of 26 stimulated EGFRs and provides a mechanism distinct from that used by constitutive 27 receptors like transferrin. A recent study also reported APPL1 displaying fast 28 retrograde movement in axonal transport hinting that the dynein-based motility that 29 we describe may be crucial in different cell types in different contexts [42] . 30
Vesicular transport is an important logistical support in the signal processing 31 machinery of the cell. As mentioned above, localization of receptors at the PNR, that 32 results in dephosphorylation and hence signal attenuation is an important step in the 33 signal processing. It is likely that not just the localization, but the rate of localization 34 from the periphery of the cell to the PNR will determine the signal sensing. In a 35 scenario where the receptors depend on the steady state dynamics of the endosomal 36 dynamics, the arrival times of the receptors at the PNR may be broadly distributed. 37
However, as described in this study, if the receptor depends on a specific activated 38 mechanism where a cohort movement of receptors ensue, the arrival times may be 1 restricted to a narrow distribution. 2 3 CONCLUSION 4
Our findings also highlight the sophisticated organization of the endosomal system's 5 interaction matrix, where transient interactions driven by specific biochemistry take 6 place in timescales of minutes. Our approach reveals a previously unknown EGFR- 
Cell lines 16
HeLa and RPE1 (ATCC) cells were incubated at 37 o C in 5% CO2 in high glucose 17
Dulbecco's modified eagle media (DMEM) (Life Technologies), supplemented with 18 10% fetal bovine serum (FBS) and 1% penicillin and streptomycin (Life Technologies). 19
Cells were seeded at a density of 200,000 per well in a 6-well plate containing 5 mm 20 glass coverslips. 21
22
Live-cell imaging 23
Cells were imaged using a lattice light sheet microscope (3i, Denver, Colarado, USA). 24
Excitation was achieved using 488, 560 and 640 nm diode lasers MPB 25 communications) at 1-5% AOTF transmittance through an excitation objective 26 (Special Optics 28.6x 0.7 NA 3.74-mm immersion lens) and is detected via a Nikon 27 CFI Apo LWD 25x 1.1 NA water immersion lens with a 2.5x tube lens. Live cells were 28 imaged in 8 mL of 37 o C-heated DMEM and were acquired with 2x Hamamatsu Orca 29 Flash 4.0 V2 sCMOS cameras using Latticescope. 600 µL of 100 nM Alexa647 labelled 30 EGF or transferrin, or 600 µL of 100 µg/µL dextran-fluorescein was added mid imaging 31 using a custom syringe-sample holder contraption that allowed precise injection of 32 the desired volume of fluorescently labelled ligands, followed by imaging media. The 33 fluorescently labelled ligand containing media were kept separated from the imaging 34 media by an air bubble ( Supplementary Fig. 1) . Similarly, non-fluorescent 600 µL of 35 100 nM ionomycin was added where indicated. Cells were serum starved in high 36 glucose DMEM medium 4 h prior to EGF addition. 37
Plasmids and transfection 1 Cells were transfected with pEGFPC1-human APPL1, a gift from Pietro De Camilli 2 (Addgene plasmid #22198) (26), GFP-APPL1-ΔPTB, a gift from Donna Webb 3 (Addgene plasmid #59768) (34), DsRed-p150 217-548, a gift from Trina Schroer 4 (Addgene plasmid #51146) (29), EEA1 TagRFP-T (Addgene plasmid #42635), a gift 5 from Silvia Corvera. Cells were transfected with a total of 1 µg DNA (plasmid of 6 interest -0.2 µg, blank DNA -0.8 µg) for single protein expression or (plasmids of 7 interest -0.2 µg + 0.2 µg, blank DNA -0.6 µg) using lipofectamine 3000 (Thermo 8
Fisher Scientific) or the Neon electroporator (Invitrogen) at 1200 mV 20 ms, 2 pulses 9 for RPE1 and 1005 mV 35 ms, 2 pulses for HeLa. HeLa cells were ensured for mild 10 expression by the following: The transfection mix consisted of APPL1 or EEA1 11 plasmids adding up to 20 % of the total DNA amount for transfection, with the rest 12 consisting of blank DNA. Secondly, it has been reported that overexpression of 13 APPL1 or EEA1 results in colocalization of APPL1 and EEA1 on Rab5 endosomes. We 14 optimized this concentration by screening for this artifact, where we see no overlap 15 of APPL1 and EEA1. Thirdly, APPL1 overexpression impairs EGFR internalization. 16
However, in all our experiments, EGF/EGFR complex is trafficked efficiently to the 17 peri-nuclear region. 18
19
Micropatterning 20
Coverslips were sonicated with 70% ethanol for 30 min and plasma cleaned for 5 min. 21
Coverslips were incubated with 1 mg/mL poly(L-lysine)-poly(ethylene-glycol) (PLL-g-22 PEG) in 1x phosphate buffered saline (PBS) at 4 o C overnight. Coverslips were then 23 placed on a chromium mask with 5 µm line patterns and illuminated for 5 min by an 24 ultraviolet lamp. The coverslips were then incubated with 20 µg/mL fibronectin 25 (Thermo Fisher Scientific) in 1x PBS with 0.02% Tween 20 and 0.04% glycerol for 1 h 26 at room temperature. Following which cells were plated onto the slips and allowed 27 to take the shape desired over 4 h ( Supplementary Fig. 4) . Co-tracking analysis: 37 Imaris 9.2.1 (Bitplane) was used to detect and track vesicles via the spot detection 1 feature following Gaussian filtering 0.1 um. The track coordinates were exported and 2 analyzed using custom codes developed in-house. Tracks which followed the same 3 trajectory were filtered by the following routine: The errors in the measurement 4 between the two channels as acquired by the two cameras were obtained by diffusing 5
Tetraspeck beads (T7279, Thermo Fischer Scientific). This estimation of error 6 provided the minimum radius for analyzing the 'co-localization' of spots belonging to 7 two distinct trajectories in two different channels. The spots were considered 8 colocalizing if they were within a sphere defined by the minimum radius: and a time 9 filter of 10 consecutive frames, where p = x, y, z coordinates as a function of time for 10 one channel and c for another ( Supplementary Fig. 3) . The effective radius of co-11 localization was set to be 500 nm to account for the sequential imaging and any 12 spatial segregation within a single endosome, based on the measurements from 13 diffusing beads. Next, once all the colocalizing spots were identified, using the 14 trajectory ID of the spots, they were filtered using a minimum time window of 3 frames 15 (12 s). We discarded any tracks that co-tracked for less than 12 s as they could be due 16 to transient interactions . Tables detailing the number of co-tracks identified with time  17 were exported, averaged for many samples and plotted using ORIGIN. 18 19
Motility analysis 20
The track coordinates were exported from Imaris. MSD analysis was performed as 21 described in previous studies [43, 44] . Briefly, the identified trajectories were used to 22 generate MSD plots. The MSD curves were fitted with the following equation: tracking and analysis workflow. All identified tracks, or tracks filtered on the basis of 10 co-trafficking by presence of both channels within a determined radius sphere at each 11 time point, were selected for ensemble MSD analysis. Based on the MSD analysis of 1 the tracks, each track was characterized as constrained, diffusive or undergoing 2 directed motion (Methods) and the tracks colored correspondingly (bottom) or 3 exported for grouped statistical analysis. (d) Graph of fraction of cargo tracks with 4 time (seconds) following EGF addition to HeLa cells transfected with APPL1 EGFP. 5
Graphs show all the EGF tracks and the fraction of EGF tracks positive for APPL1. 6
Error bars indicate standard deviation (n = 13 cells). (e) Percentages of APPL1 tracks 7 categorized as constrained (yellow), diffusive (green) and directed (magenta) motions 8 as a function of time by MSD analysis in a single cell. In addition, the blue trace shows 9 the subset of APPL1 tracks positive for EGF that displayed directed motion, 10 demonstrating that most APPL1 tracks with directed motions were also positive for 11 the EGF. Error bars correspond to the standard deviation. Scatter plots of the distance in microns of EGF endosomes from a selected centroid 1 in HeLa cells, stimulated with 100 nM EGF, at 0-2 mins and 5-7 mins post addition. 2
The grey plot represents the total amount of EGF bearing endosomes and the blue 3 plots indicate APPL1 positive endosomes bearing EGF. The inner box of the box plot 4 represents the standard deviation, the inner bar the median and the dot the mean, 5
the 'x' represents the counts within 1-99% of the sample and the horizontal bars the Timeline of relationships between EGF binding, R-GECO peaks and APPL1 1 desorption. Measured R-GECO fluorescence peak and APPL1 desorption (grey dots), 2 each dot represents a single experiment, with R-GECO peaks overlaid to mean of 3 EGF induced R-GECO peaks. 100 nM EGF was used to determine both the time of 4 APPL1 desorption (blue) and R-GECO peak (orange). Percentage of EGF bearing endosome tracks which showed confined (yellow), 7 diffusive (green) or directed (magenta) motility in HeLa cells transfected with APPL1-8 eGFP (no treatment), APPL1-ΔPTB eGFP or APPL1-eGFP and treated with 10 µM 9 erlotinib. Error bars correspond to the standard deviation. (c) Scatter plots of EGF 10 distance in microns from centroid in HeLa cells treated with 100 nM EGF at 0-2 mins 11 and 5-7-mins post addition as described in Fig. 2g . The Hela cells were either 12 transfected with APPL1-GFP (blank plot), APPL1-ΔPTB GFP (diagonal lined plot) or 13 APPL1-GFP and treated with 10 µM erlotinib (crossed plot). The inner box of the box 14 plot represents the standard deviation, the inner bar the median and the dot the In steady state cells, APPL1 (yellow semi-circles) is dispersed throughout the cell. EGF 4 binding leads to dimerization and phosphorylation of EGFR and an increase in 5
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